RE:RE:RE:PreMarket $5.62 thus far
That is a possibility but we should be between 20 to 30 dollars with our first BLA and PRV or maybe more. There should have been no deal with Kedrion. We could have kept our blood business and made plasminogen and IVIG at 100 million plus a year. Then added more proteins and the sky is the limit. FDA wouldn't have to approve each new protein and we would be off to the moon. Thompson would make insane amounts of money. It just seems way easier and more lucrative than what you suggest. But who really knows.